Prognostic Significance of Simultaneous Presence of Histological and Immunohistochemical Metastasis to Lymph Nodes in Patients with Esophageal Cancer

被引:5
作者
Kinjo, Tatsuya [1 ]
Shimoji, Hideaki [1 ]
Nagahama, Masayoshi [1 ]
Karimata, Hiroyuki [1 ]
Yoshimi, Naoki [2 ]
Nishimaki, Tadashi [1 ]
机构
[1] Univ Ryukyus, Grad Sch Med, Dept Digest & Gen Surg, Nishihara, Okinawa 9030215, Japan
[2] Univ Ryukyus, Grad Sch Med, Dept Pathol & Oncol, Nishihara, Okinawa 9030215, Japan
关键词
esophagectomy; lymph node metastasis; micro-metastasis; multidisciplinary treatment; prognostic predictor; SQUAMOUS-CELL CARCINOMA; NEOADJUVANT CHEMOTHERAPY; NODAL MICROMETASTASIS; METAANALYSIS; SURVIVAL; IMPACT;
D O I
10.5761/atcs.oa.13-00279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Presence of simultaneous pathological and immunohistochemical nodal metastasis (pNM and iNM, respectively) and/or other clinical factors may be reliable prognostic predictors of survival in esophageal cancer patients who have undergone multidisciplinary treatment. Methods: Univariate and multivariate analysis of the data collected from 77 patients who had undergone R0 esophagectomy was performed to determine the significance of presence of iNM or pNM, presence of simultaneous pNM, and other clinical factors as prognostic indicators in patients who had (n = 40) and had not (n = 37) undergone preoperative treatment. Results: Presence of pNM was found to be a significant prognostic predictor in patients who had undergone preoperative treatment, presence of iNM in patients who had not undergone preoperative treatment, and presence of simultaneous pNM and iNM in both patient groups. Multivariate analysis indicated that the sole prognostic predictor for patients who had undergone preoperative treatment was presence of simultaneous pNM and iNM while that of patients who had not undergone preoperative treatment was clinical T category. Conclusion: Assessment of simultaneous presence of pNM and iNM may facilitate highly accurate prediction of survival in esophageal cancer patients undergoing R0 esophagectomy, regardless of whether they have undergone preoperative treatment.
引用
收藏
页码:951 / 960
页数:10
相关论文
共 19 条
[1]   A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) [J].
Ando, Nobutoshi ;
Kato, Hoichi ;
Igaki, Hiroyasu ;
Shinoda, Masayuki ;
Ozawa, Soji ;
Shimizu, Hideaki ;
Nakamura, Tsutomu ;
Yabusaki, Hiroshi ;
Aoyama, Norio ;
Kurita, Akira ;
Ikeda, Kenichiro ;
Kanda, Tatsuo ;
Tsujinaka, Toshimasa ;
Nakamura, Kenichi ;
Fukuda, Haruhiko .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) :68-74
[2]   Strong Impact of Micrometastatic Tumor Cell Load in Patients with Esophageal Carcinoma [J].
Koenig, Alexandra M. ;
Prenzel, Klaus L. ;
Bogoevski, Dean ;
Yekebas, Emre F. ;
Bubenheim, Michael ;
Faithova, Lucia ;
Vashist, Yogesh K. ;
Gawad, Karim A. ;
Baldus, Stephan E. ;
Pantel, Klaus ;
Schneider, Paul M. ;
Hoelscher, Arnulf H. ;
Izbicki, Jakob R. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (02) :454-462
[3]  
Komukai S, 2002, BRIT J SURG, V89, P213
[4]   Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes [J].
Komukai, S ;
Nishimaki, T ;
Watanabe, H ;
Ajioka, Y ;
Suzuki, T ;
Hatakeyama, K .
SURGERY, 2000, 127 (01) :40-46
[5]   Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma [J].
Kosugi, SI ;
Kanda, T ;
Nakagawa, S ;
Ohashi, M ;
Nishimaki, T ;
Hatakeyama, K .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (08) :886-892
[6]   The effect of neoadjuvant chemotherapy on lymPh node micrometastases in squamous cell carcinomas of the thoracic esophagus [J].
Matsuyama, Jin ;
Doki, Yuichiro ;
Yasuda, Takushi ;
Miyata, Hiroshi ;
Fujiwara, Yoshiyuki ;
Takiguchi, Shuji ;
Yamasaki, Makoto ;
Makari, Yoichi ;
Matsuura, Nariaki ;
Mano, Masayuki ;
Monden, Morito .
SURGERY, 2007, 141 (05) :570-580
[7]   The prognostic impact of occult lymph node metastasis in cancer of the esophagus or esophago-gastric junction: systematic review and meta-analysis [J].
McGuill, M. J. ;
Byrne, P. ;
Ravi, N. ;
Reynolds, J. .
DISEASES OF THE ESOPHAGUS, 2008, 21 (03) :236-240
[8]   Intramural metastases from thoracic esophageal cancer: Local indicators of advanced disease [J].
Nishimaki, T ;
Suzuki, T ;
Tanaka, Y ;
Aizawa, K ;
Hatakeyama, K ;
Muto, T .
WORLD JOURNAL OF SURGERY, 1996, 20 (01) :32-37
[9]   Outcomes of extended radical esophagectomy for thoracic esophageal cancer [J].
Nishimaki, T ;
Suzuki, T ;
Suzuki, S ;
Kuwabara, S ;
Hatakeyama, K .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (03) :306-312
[10]  
NISHIMAKI T, 1994, CANCER, V74, P4, DOI 10.1002/1097-0142(19940701)74:1<4::AID-CNCR2820740103>3.0.CO